Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 August 2023 | Story Lacea Loader

All academic activities on the campuses of the University of the Free State (UFS) will resume face-to-face on Monday 7 August 2023.

This decision by the university’s executive management comes after campus-wide protests on 2 August 2023, and the subsequent decision to continue the academic programme online until 4 August 2023.

The university can confirm that a large number of UFS-registered students funded by the National Student Financial Aid Scheme (NSFAS) who have been excluded from payment, have received their allowances on Friday 4 August 2023. The university is aware that a small number of students have not yet onboarded successfully with eZaga – an online digital banking service tasked with disbursing direct payments to NSFAS beneficiaries. These students have been requested to urgently onboard successfully with eZaga in order to receive their allowances.

On a sectoral level, the university would also like to confirm that a statement has been issued by Universities South Africa (USAf) in which NSFAS and the Department of Higher Education, Science and Innovation are, among others, requested to urgently resolve the matter of the direct payment of allowances to students. The UFS fully supports the statement and is hopeful that an amicable and urgent solution to the matter can be found.

Protection Services and the South African Police Service remain on high alert and are monitoring the situation on the campuses closely. The necessary security measures are in place to ensure the safety of students and staff.

Prof Francis Petersen, Vice-Chancellor and Principal, will address our staff and students on 8 August 2023 about last week’s protest action. Please monitor the communication platforms for more information on this important engagement session.

message from Prof Francis Petersen, Vice-Chancellor and Principal, to staff and students about last week’s protest was also shared on 3 August 2023.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept